Welcome to LookChem.com Sign In|Join Free

CAS

  • or

138733-50-3

Post Buying Request

138733-50-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

138733-50-3 Usage

Description

2-Bromo-N-(tert-butyl)benzenesulphonamide is an organic compound characterized by a benzene ring with a bromine atom and a tert-butyl group attached to a sulphonamide functional group. It is recognized for its versatility in chemical reactions and its utility in the synthesis of a variety of compounds, including pharmaceuticals and agrochemicals.

Uses

Used in Chemical Synthesis:
2-Bromo-N-(tert-butyl)benzenesulphonamide is used as a reagent for facilitating nucleophilic substitution reactions, which are crucial for the formation of new chemical bonds in organic chemistry.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Bromo-N-(tert-butyl)benzenesulphonamide is used as a starting material for the synthesis of various drugs. Its unique structure allows for the creation of a wide range of medicinal compounds with potential therapeutic applications.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, this compound serves as a precursor in the production of pesticides, contributing to the development of effective solutions for pest control in agriculture.
Used as an Enzyme Inhibitor in Research:
2-Bromo-N-(tert-butyl)benzenesulphonamide is also utilized as a selective inhibitor of specific enzymes in biochemical and molecular biology research. This property is valuable for studying enzyme functions and for developing targeted therapies.
Overall, 2-Bromo-N-(tert-butyl)benzenesulphonamide is a significant and adaptable chemical entity with extensive applications across different sectors, from chemical synthesis to pharmaceutical and agrochemical development, as well as in scientific research.

Check Digit Verification of cas no

The CAS Registry Mumber 138733-50-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,7,3 and 3 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 138733-50:
(8*1)+(7*3)+(6*8)+(5*7)+(4*3)+(3*3)+(2*5)+(1*0)=143
143 % 10 = 3
So 138733-50-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H14BrNO2S/c1-10(2,3)12-15(13,14)9-7-5-4-6-8(9)11/h4-7,12H,1-3H3

138733-50-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Bromo-N-(tert-butyl)benzenesulfonamide

1.2 Other means of identification

Product number -
Other names 2-bromo-N-tert-butylbenzenesulfonamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:138733-50-3 SDS

138733-50-3Relevant articles and documents

Structurally Diverse Synthesis of Five-, Six-, and Seven-Membered Benzosultams through Electrochemical Cyclization

Liu, Aiyun,Guo, Tiantian,Zhang, Shuangshuang,Yang, Han,Zhang, Qi,Chai, Yonghai,Zhang, Shengyong

supporting information, p. 6326 - 6331 (2021/08/23)

We have developed a metal- and oxidant-free approach to structurally diverse synthesis of benzosultams from aryl sulfonamides through an electrochemical cyclization. Upon variation of the ortho substituent on aryl sulfonamides, five-, six-, and seven-memb

DUAL-ACTING PYRAZOLE ANTIHYPERTENSIVE AGENTS

-

Page/Page column 28, (2011/02/15)

In one aspect, the invention relates to compounds having the formula: wherein: Ar, Z, R3, R4 and R5 are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have AT1 re

Dual-acting antihypertensive agents

-

Page/Page column 43, (2008/12/07)

The invention is directed to compounds of formula I: wherein Ar, r, R3, X, and R5-7 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds of formula I have AT1 receptor antagonist activity and neprilysin inhibition activity. The invention is also directed to pharmaceutical compositions comprising such compounds; methods of using such compounds; and a process and intermediates for preparing such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 138733-50-3